NSEESOP/ESOS/ESPSESG2 Sept 2026
ICICI Lombard General Insurance Company Limited
ESOP/ESOS/ESPS
ICICI Lombard General Insurance Company Limited has informed the Exchange regarding the allotment of 4,212 equity shares under the ICICI Lombard Employees Stock Option Scheme - 2005 and ICICI Lombard Employees Stock Unit Scheme - 2023.
NSEGeneral UpdatesESG2 Sept 2026
HeidelbergCement India Limited
General Updates
HeidelbergCement India Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26, as required by SEBI regulations.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates2 Sept 2026
IRIS RegTech Solutions Limited
Analysts/Institutional Investor Meet/Con. Call Updates
IRIS RegTech Solutions Limited has informed the Exchange about the schedule of an Analyst/Investor Meeting on September 8, 2026, in Navi Mumbai, without sharing any unpublished price-sensitive information.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates2 Sept 2026
Godrej Consumer Products Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Godrej Consumer Products Limited has informed the Exchange about the link to the recording and audio/video recording of the Conference Call - Institutional Investors and Financial Analysts Meet held on September 2, 2026.
NSERecord DateDividend2 Sept 2026
HeidelbergCement India Limited
Record Date
HeidelbergCement India Limited has announced the Record Date for Dividend entitlement as 11-Sep-2026 and the 67th Annual General Meeting (AGM) on 24-Sep-2026.
NSEGeneral UpdatesESG2 Sept 2026
Welspun Living Limited
General Updates
Welspun Living Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as per the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults2 Sept 2026
Behari Lal Engineering Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Behari Lal Engineering Limited has scheduled a conference call with analysts and investors to discuss its Q1 FY27 financial results for the quarter ended June 30, 2026.
NSECopy of Newspaper Publication2 Sept 2026
Sintercom India Limited
Copy of Newspaper Publication
Sintercom India Limited has informed the Exchange about the publication of notice for its 19th Annual General Meeting to be held on September 23, 2026, through Video Conference (VC) / Other Audio-Visual Means (OAVM).
NSEShareholders meetingResults2 Sept 2026
RattanIndia Enterprises Limited
Shareholders meeting
RattanIndia Enterprises Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026 and Annual Report for FY 2025-26.
NSEInvestor Presentation▲ PositiveM&A2 Sept 2026
RPG Life Sciences Limited
Investor Presentation
RPG Life Sciences Limited has informed the Exchange about Investor Presentation, which includes details of its subsidiary RPG Active Pharma (RPGAP) acquiring Actis Generics and Raghava Life Sciences to enhance its product portfolio and capacity.
NSEShareholders meetingshareholders_meeting2 Sept 2026
HeidelbergCement India Limited
Shareholders meeting
HeidelbergCement India Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026, with details on AGM, record date, dividend entitlement, and e-voting.
NSEShareholders meetingResults2 Sept 2026
Samhi Hotels Limited
Shareholders meeting
Samhi Hotels Limited has submitted the Exchange the voting results and consolidated scrutinizer's report in respect of the 16th AGM of the Company for the financial year 2025-26 held on August 31, 2026.
NSEShareholders meetingResults2 Sept 2026
Welspun Living Limited
Shareholders meeting
Welspun Living Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026, through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The company is providing e-voting facility to its shareholders in respect of resolutions to be passed at the AGM.
NSEUpdatesResults2 Sept 2026
Waaree Energies Limited
Updates
Waaree Energies Limited has informed the Exchange regarding the 36th Annual General Meeting (AGM) of the company and the Annual Report for the Financial Year 2025-26.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesMgmt Change2 Sept 2026
RPG Life Sciences Limited
Analysts/Institutional Investor Meet/Con. Call Updates
RPG Life Sciences Limited has informed the Exchange about hosting an investors/analyst call on September 3, 2026, to discuss the company's strategic announcement.
NSEUpdates2 Sept 2026
Waaree Energies Limited
Updates
NSEGeneral UpdatesESG2 Sept 2026
Mahindra Logistics Limited
General Updates
Mahindra Logistics Limited has received an ESG rating of '73' under the category 'Leader' from NSE Sustainability Ratings & Analytics Ltd.
NSEGeneral UpdatesResults2 Sept 2026
Persistent Systems Limited
General Updates
Persistent Systems Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015, regarding the Board of Directors' meeting held on September 2, 2026, where they considered and approved proposals for alteration of the Articles of Association, long-term debt financing, and fund raising.
NSEPress Release▲ PositiveM&A2 Sept 2026
RPG Life Sciences Limited
Press Release
RPG Life Sciences Limited's wholly owned subsidiary, RPG Active Pharma Limited, has acquired the Active Pharmaceutical Ingredients (API) and Intermediates business undertaking of Raghava Life Sciences Private Limited for up to ₹135 crore. The acquisition strengthens RPG Active Pharma's integrated API play and adds approximately 300 KL of installed capacity in a state-of-the-art EU-GMP approved plant and a portfolio of 22 commercialized APIs plus 7 under development.
NSEGeneral UpdatesDivestiture2 Sept 2026
RPG Life Sciences Limited
General Updates
RPG Life Sciences Limited's wholly owned subsidiary, RPG Active Pharma Limited, has entered into a Business Transfer Agreement with Raghava Life Sciences Private Limited to acquire its Active Pharmaceutical Ingredients (APIs) and intermediates businesses on a going concern basis through a slump sale.